1. Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction. (9th August 2022) Authors: Zhu, Shimiao; Wu, Tao; Ji, Ziliang; Wu, Zhouliang; Lin, Hao; Shen, Chong; Yang, Yinggui; Zheng, Qingyou; Hu, Hailong Other Names: Zhuo Zhen-Jian Academic Editor. Journal: Disease markers Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction. (9th August 2022) Authors: Zhu, Shimiao; Wu, Tao; Ji, Ziliang; Wu, Zhouliang; Lin, Hao; Shen, Chong; Yang, Yinggui; Zheng, Qingyou; Hu, Hailong Other Names: Zhuo Zhen-Jian Academic Editor. Journal: Disease markers Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. (6th April 2020) Authors: Shen, Chong; Wu, Zhouliang; Wang, Yujie; Gao, Shen; Da, La; Xie, Linguo; Qie, Yunkai; Tian, Dawei; Hu, Hailong Journal: Cancer medicine Issue: Volume 9:Number 11(2020) Page Start: 3885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy. (February 2023) Authors: Qie, Yunkai; Cheng, Zhaoxia; Wu, Zhouliang; Qi, Feilong; Li, Bozhao; Wu, Suying; Chu, Tianjiao; Lu, Zefang; Li, Suping; Nie, Guangjun Journal: Nano today Issue: Volume 48(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MP59-19 UPDATE OF TRUCE-02: AN OPEN LABEL, SINGLE-ARM, PHASE 2 STUDY OF TILELIZUMAB COMBINED WITH NAB-PACLITAXEL FOR HIGH-RISK NON-MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA (HR-NMIBC) WHICH IS NOT COMPLETELY RESECTABLE. (May 2022) Authors: Hu, Hailong; Niu, Yuanjie; Wang, Haitao; Shen, Chong; Da, La; Zhao, Gangjian; Wang, Lili; Wu, Zhouliang; Zhang, Zhe; Li, Zhi; Jiang, Zhan; Zhan, Xuejian; Yang, Shaobo Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e1010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus. (April 2023) Authors: Zhang, Xiu-Ping; Li, Bozhao; Lu, Zefang; Hu, Ming-Gen; Zhao, Guo-Dong; Xu, Shuai; Wu, Zhouliang; Chu, Tianjiao; Qi, Feilong; Wu, Suying; Nie, Guangjun; Li, Suping; Liu, Rong Journal: Nano today Issue: Volume 49(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PD10-07 UPDATE OF TRUCE-01: NEOADJUVANT TISLELIZUMAB COMBINED WITH NAB-PACLITAXEL FOR MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA. (May 2022) Authors: Hu, Hailong; Niu, Yuanjie; Wang, Haitao; Shen, Chong; Zhao, Gangjian; Da, La; Wang, Lili; Wu, Zhouliang; Li, Zhi; Chen, Houyuan; Zhan, Xuejian; Jiang, Zhan; Zhang, Zhe Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reducing Postoperative Recurrence of Early‐Stage Hepatocellular Carcinoma by a Wound‐Targeted Nanodrug. Issue 20 (7th May 2022) Authors: li, Bozhao; Zhang, Xiuping; Wu, Zhouliang; Chu, Tianjiao; Yang, Zhenlin; Xu, Shuai; Wu, Suying; Qie, Yunkai; Lu, Zefang; Qi, Feilong; Hu, Minggen; Zhao, Guodong; Wei, Jingyan; Zhao, Yuliang; Nie, Guangjun; Meng, Huan; Liu, Rong; Li, Suping Journal: Advanced science Issue: Volume 9:Issue 20(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study. Issue 5 (February 2016) Authors: Shen, Zhonghua; Xie, Linguo; Chen, Tao; Tian, Dawei; Liu, xiaoteng; Xu, Hao; Zhang, Yu; Wu, Zhouliang; Sha, Nan; Xing, Chen; Ding, Na; Hu, Hailong; Wu, Changli Editors: Mubarak., Muhammed Journal: Medicine Issue: Volume 95:Issue 5(2016) Page Start: e2625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study. Issue 5 (February 2016) Authors: Shen, Zhonghua; Xie, Linguo; Chen, Tao; Tian, Dawei; Liu, xiaoteng; Xu, Hao; Zhang, Yu; Wu, Zhouliang; Sha, Nan; Xing, Chen; Ding, Na; Hu, Hailong; Wu, Changli Other Names: Mubarak. Muhammed section editor. Journal: Medicine Issue: Volume 95:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗